Publications by authors named "Jane Goddard"

Claim this Profile
A
Acetylcysteine has No Mechanistic Effect in Patients at Risk of Contrast-Induced Nephropathy: A Failure of Academic Clinical Science.
Euan A Sandilands, Jessica M B Rees, Khuram Raja, Neeraj Dhaun, Emma E Morrison, Jane Goddard

Clin Pharmacol Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Man Demonstration of Direct Endothelin-Mediated Natriuresis and Diuresis.
Robert W Hunter, Rebecca Moorhouse, Tariq E Farrah, Iain M MacIntyre, Takae Asai, Jane Goddard

Hypertension· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.
Boris B Betz, Sara J Jenks, Andrew D Cronshaw, Douglas J Lamont, Carolynn Cairns, Jane Goddard

Kidney Int· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective management of end-stage renal failure within a conservative care programme.
Neeraj Dhaun, Johanna Mackenzie, Jane Goddard, Caroline Whitworth

BMJ Qual Improv Rep· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism.
Neeraj Dhaun, Jale Yuzugulen, Robert A Kimmitt, Elizabeth G Wood, Pajaree Chariyavilaskul, Jane Goddard

J Am Heart Assoc· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease.
Ana Reis, Alisa Rudnitskaya, Pajaree Chariyavilaskul, Neeraj Dhaun, Vanessa Melville, Jane Goddard

J Lipid Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diurnal variation in blood pressure and arterial stiffness in chronic kidney disease: the role of endothelin-1.
Neeraj Dhaun, Rebecca Moorhouse, Iain M MacIntyre, Vanessa Melville, Wilna Oosthuyzen, Jane Goddard

Hypertension· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential therapeutic role of phosphodiesterase type 5 inhibition in hypertension and chronic kidney disease.
Kayleigh E Brown, Neeraj Dhaun, Jane Goddard, David J Webb

Hypertension· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD.
Neeraj Dhaun, Vanessa Melville, Scott Blackwell, Dinesh K Talwar, Neil R Johnston, Jane Goddard

J Am Soc Nephrol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the best method of proteinuria measurement in clinical trials of endothelin receptor antagonists?
Jonathan D Towler, Neeraj Dhaun, Margaret MacDougall, Vanessa Melville, Jane Goddard

Life Sci· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for metabolic syndrome independently predict arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidity.
Pajaree Lilitkarntakul, Neeraj Dhaun, Vanessa Melville, Debbie Kerr, David J Webb, Jane Goddard

Diabetes Care· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocol.
Euan A Sandilands, Sharon Cameron, Frances Paterson, Sam Donaldson, Lesley Briody, Jane Goddard

BMC Clin Pharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin antagonism in patients with nondiabetic chronic kidney disease.
Neeraj Dhaun, Jane Goddard, David J Webb

Contrib Nephrol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic selective endothelin A receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease.
Neeraj Dhaun, Neil R Johnston, Jane Goddard, David J Webb

Hypertension· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity.
Pajaree Lilitkarntakul, Neeraj Dhaun, Vanessa Melville, Scott Blackwell, Dinesh K Talwar, Jane Goddard

Atherosclerosis· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease.
Neeraj Dhaun, Iain M MacIntyre, Debbie Kerr, Vanessa Melville, Neil R Johnston, Jane Goddard

Hypertension· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal dysfunction does not affect the peripheral-to-central arterial pressure transfer function.
Rupert A Payne, Pajaree Lilitkarntakul, Neeraj Dhaun, Vanessa Melville, Takae Asai, Jane Goddard

Hypertension· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater functional ETB receptor antagonism with bosentan than sitaxsentan in healthy men.
Iain M MacIntyre, Neeraj Dhaun, Pajaree Lilitkarntakul, Vanessa Melville, Jane Goddard

Hypertension· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute renal dysfunction following hip fracture.
Simon J Bennet, Olivia M B Berry, Jane Goddard, John F Keating

Injury· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An endothelin antagonist for resistant hypertension.
Neeraj Dhaun, Jane Goddard, David J Webb

Lancet· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney disease.
Neeraj Dhaun, Iain M Macintyre, Vanessa Melville, Pajaree Lilitkarntakul, Neil R Johnston, Jane Goddard

Hypertension· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease.
Neeraj Dhaun, Iain M Macintyre, Vanessa Melville, Pajaree Lilitkarntakul, Neil R Johnston, Jane Goddard

Hypertension· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis.
Neeraj Dhaun, Pajaree Lilitkarntakul, Iain M Macintyre, Eline Muilwijk, Neil R Johnston, Jane Goddard

Am J Physiol Renal Physiol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ambrisentan and its role in the management of pulmonary arterial hypertension.
Iain M Macintyre, Neeraj Dhaun, Jane Goddard, David J Webb

Drugs Today (Barc)· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sitaxsentan sodium for pulmonary hypertension.
Iain M MacIntyre, Neeraj Dhaun, Jane Goddard, David J Webb

Drugs Today (Barc)· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis